Overview

Dexmedetomidine Cardiovascular Safety in Pediatric Burn Patients

Status:
Completed
Trial end date:
2008-12-30
Target enrollment:
Participant gender:
Summary
Dexmedetomidine is a sedative drug approved for adult patients, intubated, in intensive care units. We are studying whether this drug is cardiovascularly safe in pediatric patients who have recently been burned.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Dexmedetomidine